Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study.
Chandna, Arjun
; Mahajan, Raman; Gautam, Priyanka; Mwandigha, Lazaro; PRIORITISE Study Investigators; Kumar, Pragya; Varghese, George M; Koshiaris, Constantinos; Lubell, Yoel; and Burza, Sakib
(2022)
Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study.
Open forum infectious diseases, 9 (10).
ofac526-.
ISSN 2328-8957
DOI: 10.1093/ofid/ofac526
; Mahajan, Raman; Gautam, Priyanka; Mwandigha, Lazaro; PRIORITISE Study Investigators; Kumar, Pragya; Varghese, George M; Koshiaris, Constantinos; Lubell, Yoel; and Burza, Sakib
(2022)
Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019: A Prospective Cohort Study.
Open forum infectious diseases, 9 (10).
ofac526-.
ISSN 2328-8957
DOI: 10.1093/ofid/ofac526
Efficient resource allocation is essential for effective pandemic response. We measured host biomarkers in 420 patients presenting with moderate coronavirus disease 2019 and found that different biomarkers predict distinct clinical outcomes. Interleukin (IL)-1ra, IL-6, IL-10, and IL-8 exhibit dose-response relationships with subsequent disease progression and could potentially be useful for multiple use-cases.
-
picture_as_pdf - Host Biomarkers Reflect Prognosis in Patients Presenting With Moderate Coronavirus Disease 2019 A Prospective Cohort Study.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution 4.0
Downloads